Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast

Abstract

Radiotherapy reduced the absolute 10-year risk of any ipsilateral breast event, and it was effective regardless of the age at diagnosis, extent of breast-conserving surgery, use of tamoxifen, method of DCIS detection, margin status, focality, grade, comedonecrosis, architecture, or tumor size.

Keywords

• Randomized trial
• radiotherapy
• carcinoma